Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Stokes

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Human Immunology|June 9, 2009
Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-FcGeorge Vlad, Michael B Stokes, Zhuoru Liu, et al.
Journal of the American Society of Nephrology : JASN|April 20, 2000
Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney diseaseFrank Eitner, Yan Cui, Kelly L Hudkins, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 29, 2018
Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 CasesJae-Hyung Chang, S Ali Husain, Dominick Santoriello, et al.
BMJ Open|August 10, 2021
Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiencySamuel J Tu, Adrian D Elliott, Nicole Hanna-Rivero, et al.
Circulation|May 3, 2019
Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant RecipientsNitesh N Rao, Michael B Stokes, Adil Rajwani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2021
The clinical significance of receiving a kidney allograft from deceased donor with chronic histologic changesIbrahim Batal, Geo Serban, Sumit Mohan, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2017
The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical CorrelationsVolker Nickeleit, Harsharan K Singh, Parmjeet Randhawa, et al.
Kidney360|April 4, 2022
Long-Term Impact of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients: A 5-Year Follow-Up Observational Cohort StudyTania Salehi, Nicholas J Montarello, Nishant Juneja, et al.
Kidney International|June 11, 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsFrank B Cortazar, Kristen A Marrone, Megan L Troxell, et al.
Kidney International|October 6, 2018
Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allograftsDominick Santoriello, Syed A Husain, Sacha A De Serres, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Human Immunology|June 9, 2009
Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-FcGeorge Vlad, Michael B Stokes, Zhuoru Liu, et al.
Journal of the American Society of Nephrology : JASN|April 20, 2000
Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney diseaseFrank Eitner, Yan Cui, Kelly L Hudkins, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 29, 2018
Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 CasesJae-Hyung Chang, S Ali Husain, Dominick Santoriello, et al.
BMJ Open|August 10, 2021
Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiencySamuel J Tu, Adrian D Elliott, Nicole Hanna-Rivero, et al.
Circulation|May 3, 2019
Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant RecipientsNitesh N Rao, Michael B Stokes, Adil Rajwani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2021
The clinical significance of receiving a kidney allograft from deceased donor with chronic histologic changesIbrahim Batal, Geo Serban, Sumit Mohan, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2017
The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical CorrelationsVolker Nickeleit, Harsharan K Singh, Parmjeet Randhawa, et al.
Kidney360|April 4, 2022
Long-Term Impact of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients: A 5-Year Follow-Up Observational Cohort StudyTania Salehi, Nicholas J Montarello, Nishant Juneja, et al.
Kidney International|June 11, 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsFrank B Cortazar, Kristen A Marrone, Megan L Troxell, et al.
Kidney International|October 6, 2018
Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allograftsDominick Santoriello, Syed A Husain, Sacha A De Serres, et al.
Pageof 8